Visit COVID-19 resources

[Skip to Content]

Trainee confidence managing ocular trauma – (Trainee confidence managing ocular trauma, Published online: 2019-01-07; | doi:10.1038/s41433-018-0328-4)

Jan 07
2019

Trainee confidence managing ocular trauma Trainee confidence managing ocular trauma, Published online: 07 January 2019; doi:10.1038/s41433-018-0328-4 Trainee confidence managing ocular trauma

  • 7 January 2019

Ocular abnormalities and complications in anterior megalophthalmos: a case series – (Ocular abnormalities and complications in anterior megalophthalmos: a case series, Published online: 2019-01-07; | doi:10.1038/s41433-018-0329-3)

Jan 07
2019

Ocular abnormalities and complications in anterior megalophthalmos: a case series Ocular abnormalities and complications in anterior megalophthalmos: a case series, Published online: 07 January 2019; doi:10.1038/s41433-018-0329-3 Ocular abnormalities and complications in anterior megalophthalmos: a case series

  • 7 January 2019

Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up – (Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up, Published online: 2019-01-04; | doi:10.1038/s41433-018-0323-9)

Jan 04
2019

Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up Effectiveness and safety of accelerated (9 mW/cm<sup>2</sup>) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up, Published online: 04 January 2019; doi:10.1038/s41433-018-0323-9 Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: a 24-month follow-up

  • 4 January 2019

Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy – (Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy, Published online: 2019-01-04; | doi:10.1038/s41433-018-0315-9)

Jan 04
2019

Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy, Published online: 04 January 2019; doi:10.1038/s41433-018-0315-9 Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy

  • 4 January 2019

Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years – (Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years, Published online: 2019-01-04; | doi:10.1038/s41433-018-0309-7)

Jan 04
2019

Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years, Published online: 04 January 2019; doi:10.1038/s41433-018-0309-7 Short-duration multiple-session subthreshold micropulse yellow laser (577 nm) for chronic central serous chorioretinopathy: results at 3 years

  • 4 January 2019